;

Global Compliance and Litigation

A whole new world: A global view on anti corruption priorities

Recalls, private enforcement, and rising liability: PLD reshaping EU life sciences risks

EU Member States implement Product Liability Directive: Snapshots for France, Germany, Italy and Spain

The role of CE marking and marketing authorizations in UPC case law: A springboard to long-arm jurisdiction

UPC litigation clarifying when preliminary injunctions may be granted

Important class action rulings in life sciences: 2025 and what lies ahead

New German arbitration solutions for third-party involvement minimize risk and complexity

UK Provider Selection Regime: Trends in panel decisions

Policy meets enforcement: How the Trump Administration is leveraging the False Claims Act on gender affirming care

The new lobbying landscape: Implications for life sciences in Europe

Eurasian Pharma Registry: Patent enforcement benefits for the pharmaceutical industry

Managing risks from compulsory licenses based on patent non-use in the Eurasian Economic Union